SJ Medical
The global balloon angioplasty market is witnessing a paradigm shift driven by technological miniaturization and the demand for minimally invasive procedures. As healthcare systems move toward outpatient-based intervention, the reliability of catheter suppliers has become the cornerstone of clinical success. Balloon angioplasty catheters are no longer just tools for dilation; they are complex instruments integrating advanced material science for trackability, pushability, and crossability in increasingly challenging anatomies.
Hangzhou SJ Medical Co., Ltd. (est. 2015) stands at the forefront of this evolution. Our dedicated focus on R&D, manufacturing, and commercialization of vascular interventional medical devices ensures that healthcare providers worldwide receive solutions that prioritize patient safety and procedural efficiency.
Our product portfolio, ranging from coronary and peripheral balloon catheters to advanced access devices, is built upon a foundation of rigorous quality control. We do not just manufacture; we engineer reliability. By leveraging high-standard cleanroom environments (including localized hundred-class areas), we ensure every catheter meets the highest international benchmarks.
For international procurement managers, selecting a supplier involves balancing clinical efficacy with regulatory compliance. SJ Medical provides a comprehensive solution for global distribution:
Q: What standards do you adhere to for catheter production?
A: We strictly follow GMP standards. Our facility includes a million-class clean workshop with localized hundred-class zones for critical device assembly, ensuring zero contamination.
Q: Can you support OEM/ODM requirements?
A: Yes. We have deep experience in custom medical laser cutting, Ni-Ti stent processing, and proprietary catheter design tailored to specific clinical needs.
Q: Which regions does SJ Medical currently export to?
A: We have established long-term partnerships across Europe, Asia, the Middle East, and Africa, including key markets like Finland, Italy, Spain, France, Turkey, and India.